Showing results (181-190 of 296) with videos related to
Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|September 1, 1996
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantationM W Fried, D G Connaghan, S Sharma, et al.Plos One|September 20, 2019
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.Gastroenterology|January 30, 2007
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis CYing Huang, Jordan J Feld, Ronda K Sapp, et al.Digestive Diseases and Sciences|June 1, 2021
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBVDavid E Bernstein, Huy N Trinh, Eugene R Schiff, et al.Bulletin of the Hospital for Joint Disease (2013)|May 13, 2024
Matrix-Induced Autologous Chondrocyte Implantation Versus Autologous Chondrocyte Implantation of the Knee A Retrospective ComparisonAmit K Manjunath, Jordan W Fried, Erin F Alaia, et al.Journal of Biomedical Optics|March 17, 2017
Pressure injury prediction using diffusely scattered lightDavid Diaz, Alec Lafontant, Michael Neidrauer, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 15, 2001
Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndromeH M Lasch, M W Fried, S L Zacks, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled studyElizabeth W Jackson, Steven Zacks, Sandra Zinn, et al.Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.Pageof 30